XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Sep. 28, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 6.0 $ 4.1
Restricted cash 2.4 2.2
Accounts and other receivables, net of allowances of $0.4 and $0.3, respectively 51.0 58.8
Prepayments and accrued income 6.0 4.6
Inventories 95.1 83.6
Current assets held-for-sale 6.8 22.5
Total current assets 167.3 175.8
Non-current assets    
Property, plant and equipment, net 58.8 62.8
Right-of-use assets from operating leases 11.1 11.5
Goodwill 69.2 67.0
Intangibles, net 11.1 11.5
Deferred tax assets 4.7 4.1
Pensions and other retirement benefits 54.8 49.3
Investments and loans to joint ventures and other affiliates 0.4 0.4
Total assets 377.4 382.4
Current liabilities    
Current maturities of long-term debt and short-term borrowing 25.0 3.1
Accounts payable 23.2 29.6
Accrued liabilities 28.8 24.0
Taxes on income 8.2 5.6
Current liabilities held-for-sale 2.8 12.8
Other current liabilities 13.0 18.6
Total current liabilities 101.0 93.7
Non-current liabilities    
Long-term debt 18.3 42.0
Pensions and other retirement benefits 0.1 0.1
Deferred tax liabilities 13.9 14.0
Other non-current liabilities 12.5 13.1
Total liabilities 145.8 162.9
Commitments and contingencies (Note 16)
Shareholders' equity    
Ordinary shares of £0.50 par value; authorized 40,000,000 shares for 2025 and 2024; issued 28,944,000 for 2025 and 2024; outstanding 26,721,510 and 26,742,074 for 2025 and 2024, respectively 26.5 26.5
Additional paid-in capital 227.9 226.1
Treasury shares (26.4) (24.9)
Company shares held by ESOP (0.7) (0.8)
Retained earnings 109.0 108.7
Accumulated other comprehensive loss (104.7) (116.1)
Total shareholders' equity 231.6 219.5
Total liabilities and shareholders' equity $ 377.4 $ 382.4